Results 51 to 60 of about 46,694 (224)
ABSTRACT Background The currently high pertussis‐related morbidity and mortality among infants has led to increased international attention for pertussis vaccination during pregnancy. We studied the safety of maternal pertussis vaccination in the Netherlands with respect to neonatal health. Methods Data from the cohort the Dutch Pregnancy Drug Register
Petra J. Woestenberg +7 more
wiley +1 more source
Emergence of Bordetella holmesii–Associated Pertussis-Like Illness, Northern India, 2019–2023
We investigated Bordetella holmesii and Bordetella pertussis in 935 suspected pertussis cases in northern India (2019–2023) using PCR and serology. B. holmesii showed increased prevalence in pertussis cases, particularly in older children, highlighting ...
Nishant Shekhar +12 more
doaj +1 more source
ABSTRACT Background Infection is a significant cause of morbidity and mortality in pediatric oncology patients, especially during neutropenia. While bacterial infections are traditionally considered the primary cause of febrile neutropenia, the growing use of respiratory pathogen panels (RPPs) for viral detection in children has not been extensively ...
Farrah Gaston +3 more
wiley +1 more source
isolates in Finland: Serotype and fimbrial expression [PDF]
Background Bordetella pertussis causes whooping cough or pertussis in humans. It produces several virulence factors, of which the fimbriae are considered adhesins and elicit immune responses in the host. B.
Eriikka Heikkinen +6 more
core +1 more source
ABSTRACT Severe rhinovirus (RV)/enterovirus (EV) respiratory infections in pediatric patients increased in the US during 2022–2023. This study aimed to characterize RV/EV genetic diversity among hospitalized children in Wisconsin and describe demographic and clinical factors of patients by RV/EV type.
Hannah L. Litwak +13 more
wiley +1 more source
Sensitivity and specificity of single IgA and IgG antibody concentrations for early diagnosis of pertussis in adults: an evaluation for outbreak management in public health practice [PDF]
Background: An accurate, practical laboratory test is needed to confirm clinical diagnosis of pertussis in adults during the first 3 symptomatic weeks, when treatment is effective and transmission can be interrupted.
Mertens, PLJM (Paulus Leonardus Johannes Mar) +3 more
core +1 more source
Airborne Transmission of Bordetella pertussis [PDF]
Pertussis is a contagious, acute respiratory illness caused by the bacterial pathogen Bordetella pertussis. Although it is widely believed that transmission of B. pertussis occurs via aerosolized respiratory droplets, no controlled study has ever documented airborne transmission of pertussis.
Jason M, Warfel +2 more
openaire +2 more sources
ABSTRACT Aim In April 2024 nirsevimab, a long‐acting respiratory syncytial virus (RSV)‐specific monoclonal antibody, was made available free of charge to all newborn infants in Queensland. We aimed to explore the community‐level impact of a nirsevimab‐based prevention program on RSV detection percentages among infants aged ≤ 3 months in Queensland ...
Asmaa El‐Heneidy +6 more
wiley +1 more source
Do not let perfect be the enemy of good: the current reality of Bordetella testing
Diagnosis of Bordetella pertussis is made by using polymerase chain reaction (PCR) to detect insertion sequence 481 (IS481). However, IS481 is found in both B. pertussis and Bordetella holmesii. In a recent study, Cole et al.
Rebecca Yee
doaj +1 more source
Objectives: Pertussis is a highly transmissible acute respiratory infection caused by the bacterial pathogen Bordetella pertussis. The purpose of this study was to develop a rapid, simple and sensitive diagnostic test for detecting this pathogen. Methods:
Rui-qing Zhang +11 more
doaj +1 more source

